You’re using a public version of DrugPatentWatch with 1 free search available | Register to unlock more free searches. CREATE FREE ACCOUNT

Serving leading biopharmaceutical companies globally:

AstraZeneca
Harvard Business School
Johnson and Johnson
Dow
Express Scripts
Colorcon

Last Updated: September 27, 2023

Investigational Drug Information for Vinflunine


✉ Email this page to a colleague

« Back to Dashboard


What is the drug development status for Vinflunine?

Vinflunine is an investigational drug.

There have been 34 clinical trials for Vinflunine. The most recent clinical trial was a Phase 3 trial, which was initiated on January 13th 2015.

The most common disease conditions in clinical trials are Carcinoma, Transitional Cell, Carcinoma, and Urinary Bladder Neoplasms. The leading clinical trial sponsors are Bristol-Myers Squibb, Pierre Fabre Medicament, and SCRI Development Innovations, LLC.

There is one US patent protecting this investigational drug and fifteen international patents.

Recent Clinical Trials for Vinflunine
TitleSponsorPhase
Study of Sacituzumab Govitecan-hziy (IMMU-132) Versus Treatment of Physician's Choice in Participants With Metastatic or Locally Advanced Unresectable Urothelial CancerGilead SciencesPhase 3
Study of Sacituzumab Govitecan-hziy (IMMU-132) Versus Treatment of Physician's Choice in Participants With Metastatic or Locally Advanced Unresectable Urothelial CancerImmunomedics, Inc.Phase 3
Niraparib in Combination With Cabozantinib (XL184) in Patients With Advanced Urothelial Cancer (NICARAGUA)Apices Soluciones S.L.Phase 1/Phase 2

See all Vinflunine clinical trials

Clinical Trial Summary for Vinflunine

Top disease conditions for Vinflunine
Top clinical trial sponsors for Vinflunine

See all Vinflunine clinical trials

US Patents for Vinflunine

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Vinflunine ⤷  Try a Trial Heat shock protein 70 (hsp-70) receptor ligands Duke University (Durham, NC) ⤷  Try a Trial
Vinflunine ⤷  Try a Trial Compounds and their methods of use Agios Pharmaceuticals, Inc. (Cambridge, MA) ⤷  Try a Trial
Vinflunine ⤷  Try a Trial Use of inhibitors of Bruton'S tyrosine kinase (Btk) Pharmacyclics LLC (Sunnyvale, CA) ⤷  Try a Trial
Vinflunine ⤷  Try a Trial Use of inhibitors of Bruton's tyrosine kinase (Btk) Pharmacyclics LLC (Sunnyvale, CA) ⤷  Try a Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Vinflunine

Drugname Country Document Number Estimated Expiration Related US Patent
Vinflunine World Intellectual Property Organization (WIPO) WO2015148714 2034-03-25 ⤷  Try a Trial
Vinflunine Australia AU2015231053 2034-03-21 ⤷  Try a Trial
Vinflunine Brazil BR112016021620 2034-03-21 ⤷  Try a Trial
Vinflunine Canada CA2943339 2034-03-21 ⤷  Try a Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Harvard Business School
Johnson and Johnson
Dow
Express Scripts
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.